1064
D.S.-H. Chan et al. / Biochimie 93 (2011) 1055e1064
[9] P. Wu, D.-L. Ma, C.-H. Leung, S.-C. Yan, N. Zhu, R. Abagyan, C.-M. Che, Stabi-
lization of G-Quadruplex DNA with platinum(ii) schiff base complexes:
luminescent probe and down-regulation of c-myc oncogene expression,
Chemistry 15 (2009) 13008e13021.
[10] H.-M. Lee, D.S.-H. Chan, F. Yang, H.-Y. Lam, S.-C. Yan, C.-M. Che, D.-L. Ma, C.-
H. Leung, Identification of natural product fonsecin B as a stabilizing ligand of
c-myc G-quadruplex DNA by high-throughput virtual screening, Chem.
Commun. 46 (2010) 4680e4682.
[20] A.H. Lewin, H.A. Navarro, S.W. Mascarella, Structure-activity correlations for
-phenethylamines at human trace amine receptor 1, Bioorg. Med. Chem. 16
b
(2008) 7415e7423.
[21] L. Strekowski, D.F. Hou, R.L. Wydra, R.F. Schinazi, A synthetic route to 3-
(dialkylamino)phenothiazin-5-ium salts and 3,7-disubstituted derivatives
containing two different amino groups, J. Heterocycl. Chem. 30 (1993)
1693e1695.
[22]
(a) M. Totrov, R. Abagyan, Flexible protein-ligand docking by global
energy optimization in internal coordinates, Proteins (1997) 215e220
Suppl. 1;
[11]
(a) D.W. Carley, Drug repurposing: identify, develop and commercialize
new uses for existing or abandoned drugs. Part II, Idrugs 8 (2005)
310e313;
(b) D.-L. Ma, T.-S. Lai, F.-Y. Chan, W.-H. Chung, R. Abagyan, Y.-C. Leung, K.-
Y. Wong, Discovery of a drug-like G-quadruplex binding ligand by
high-throughput docking, ChemMedChem. 3 (2008) 881e884.
(b) C.R. Chong, D.J. Sullivan Jr., New uses for old drugs, Nature 448 (2007)
645e646;
(c) P. Schneider, Y. Tanrikulu, G. Schneider, Self-organizing maps in drug
discovery: compound library design, scaffold-hopping, repurposing,
Curr. Med. Chem. 16 (2009) 258e266.
[23] G.N. Parkinson, M.P.H. Lee, S. Neidle, Crystal structure of parallel quadruplexes
from human telomeric DNA, Nature 417 (2002) 876e880.
[24] A. Ambrus, D. Chen, J. Dai, R.A. Jones, D. Yang, Solution structure of the biolog-
ically relevant G-quadruplex element in the human c-myc promoter. Implica-
tions for G-quadruplex stabilization, Biochemistry 44 (2005) 2048e2058.
[12] J.A. DiMasi, R.W. Hansen, H.G. Grabowski, The price of innovation: new esti-
mates of drug development costs, J. Health Econ. 22 (2003) 151e185.
[13]
(a) I.D. Kuntz, Structure-based strategies for drug design and discovery,
Science 257 (1992) 1078e1082;
(b) J. Bajorath, Integration of virtual and high-throughput screening, Nat.
Rev. Drug Discov. 1 (2002) 882e894;
(c) B.K. Shoichet, Virtual screening of chemical libraries, Nature 432 (2004)
862e865;
(d) D.S.-H. Chan, H.-M. Lee, F. Yang, C.-M. Che, C.C.L. Wong, R. Abagyan, C.-
H. Leung, D.-L. Ma, Structure-based discovery of natural product-Like
TNF-? inhibitors, Angewandte Chemie 49 (2010) 2860e2864;
(e) C.-H. Leung, D.S.-H. Chan, H. Yang, R. Abagyan, D.-L. Ma, A natural
product-like inhibitor of NEDD8-activating enzyme, Chem. Commun
47 (2011) 2511e2513;
(f) C.-H. Leung, D.S.-H. Chan, M.H.-T. Kwan, Z. Cheng, D.-L. Ma, Structure-
based repurposing of FDA-approved drugs as TNF-α inhibitors,
[25]
(a) S.L. Narsapur, G.J. Naylor, Methylene blue. A possible treatment for
manic depressive psychosis, J. Affect. Disord. 5 (1983) 155e161;
(b) J. Clutton-Brock, Two cases of poisoning by contamination of nitrous
oxide with higher oxides of nitrogen during anaesthesia, Br. J. Anaesth.
39 (1967) 388e392;
(c) J. Clifton 2nd, J.B. Leikin, Methylene blue, Am. J. Ther. 10 (2003)
289e291;
(d) M. Wainwright, L. Amaral, The phenothiazinium chromophore and the
evolution of antimalarial drugs, Trop. Med. Int. Health 10 (2005)
501e511;
(e) J.P. Tardivo, G.A. Del, d.O.C. Santos, D.S. Gabrielli, H.C. Junqueira,
D.B. Tada, D. Severino, R.d.F. Turchiello, M.S. Baptista, Methylene blue
in photodynamic therapy: from basic mechanisms to clinical appli-
cations, Photodiagnosis Photodyn. Ther. 2 (2005) 175e191.
[26] H. Sun, J. Xiang, Y. Zhang, G. Xu, L. Xu, Y. Tang, Spectroscopic studies of the
interaction between methylene blue and G-quadruplex, Chin. Sci. Bull. 51
(2006) 1687e1692.
[27] P. Ragazzon, J.B. Chaires, Use of competition dialysis in the discovery of G-
quadruplex selective ligands, Methods 43 (2007) 313e323.
[14] W.H. Bisson, A.V. Cheltsov, N. Bruey-Sedano, B. Lin, J. Chen, N. Goldberger,
L.T. May, A. Christopoulos, J.T. Dalton, P.M. Sexton, X.K. Zhang, R. Abagyan,
Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed
drugs, Proc. Natl. Acad. Sci. U S A 104 (2007) 11927e11932.
[15]
(a) J. Sambrook, E.F. Fritsch, T.E. Maniatis, Molecular Cloning, a Laboratory
Manual, second ed. (1989) E.3 and E.10;
(b) G. Felsenfeld, S.Z. Hirschman, A neighbor-interaction analysis of the
hypochromism and spectra of DNA, J. Mol. Biol. 13 (1965) 407e427.
[28] J. Seenisamy, E.M. Rezler, T.J. Powell, D. Tye, V. Gokhale, C.S. Joshi, A. Siddiqui-
Jain, L.H. Hurley, The dynamic character of the G-quadruplex element in the c-
MYC promoter and modification by TMPyP4, J. Am. Chem. Soc. 126 (2004)
8702e8709.
[16] K. Suntharalingam, A.J.P. White, R. Vilar, Two metals are better than one:
investigations on the interactions between dinuclear metal complexes and
quadruplex DNA, Inorg. Chem. 49 (2010) 8371e8380.
[29] Y. Wang, A. Zhou, Spectroscopic studies on the binding of methylene blue
with DNA by means of cyclodextrin supramolecular systems, J. Photochem.
Photobiol. A Chem. 190 (2007) 121e127.
[17] C.V. Kumar, E.H. Asuncion, DNA binding studies and site selective fluorescence
sensitization of an anthryl probe, J. Am. Chem. Soc. 115 (1993) 8547e8553.
[18] O.M. New, D. Dolphin, Design and synthesis of novel phenothiazinium
photosensitizer derivatives, Eur. J. Org. Chem. (2009) 2675e2686.
[30] M. Hossain, P. Giri, G.S. Kumar, DNA intercalation by quinacrine and methy-
lene blue: a comparative binding and thermodynamic characterization study,
DNA Cell Biol. 27 (2008) 81e90.
[31] L.-P. Bai, M. Hagihara, Z.-H. Jiang, K. Nakatani, Ligand binding to tandem G
quadruplexes from human telomeric DNA, ChemBioChem 9 (2008) 2583e2587.
[32] T.-C. He, A.B. Sparks, C. Rago, H. Hermeking, L. Zawel, C.L.T. Da, P.J. Morin,
B. Vogelstein, K.W. Kinzler, Identification of c-MYC as a target of the APC
pathway, Science (Washington, D. C.) 281 (1998) 1509e1512.
[19]
(a) T.B. Lanni, K.L. Greene, C.N. Kolz, K.S. Para, M. Visnick, J.L. Mobley,
D.T. Dudley, T.J. Baginski, M.B. Liimatta, Design and synthesis of phe-
nethyl benzo[1,4]oxazine-3-ones as potent inhibitors of PI3Kinase
g,
Bioorg. Med. Chem. Lett. 17 (2007) 756e760;
(b) A.R. Thornton, V.I. Martin, S.B. Blakey,
p
a
-Nucleophile traps for metal-
versatile process for the
a-aminocyclopropanes and b-aminostyrenes, J. Am.
[33] R.K. Thakur, P. Kumar, K. Halder, A. Verma, A. Kar, J.L. Parent, R. Basundra,
A. Kumar, S. Chowdhury, Metastases suppressor NM23-H2 interaction with G-
quadruplex DNA within c-MYC promoter nuclease hypersensitive element
induces c-MYC expression, Nucleic Acids Res. 37 (2009) 172e183.
lonitrene/alkyne cascade reactions:
synthesis of
Chem. Soc. 131 (2009) 2434e2435.